TNFRSF8 and mast cell neoplasm: Previous studies have shown that CD30 is predominantly expressed in advanced mast cell neoplasms, suggesting that neoplastic mast cells may enhance tumor growth and survival through CD30-related NF-κB signaling and autocrine interactions between CD30 and its ligands [11].